This conference will update you on advances in personalised cancer medicine, focusing on targeted and immunological therapeutic approaches. It will cover the challenges of tumour heterogeneity, drug resistance and the influence of the tumour microenvironment.​
Target audience: The conference will bring together basic, translational and clinical scientists, as well as physicians engaged in the challenges of personalised medicine, the development of new therapeutics and clinical implementation.
Target audience: The conference will bring together basic, translational and clinical scientists, as well as physicians engaged in the challenges of personalised medicine, the development of new therapeutics and clinical implementation.
